Italy DNA Vaccine market is anticipated to grow at a CAGR 41.3% during the forecast period. Most of Italy’s economy is driven by manufacturers of high-quality consumer goods produced by small and medium-sized enterprises. Similar to the UK and Germany the surviving infant rate in Italy is almost 100%. In 2017, the surviving infant rate was 484 out of 485. The major disease reported in the country is measles, rubella and tetanus. As per WHO, in 2017 the reported cases of the measles, mumps, pertussis were 4,050,508 and 510 respectively. No certain cases were reported for the following diseases from 2013 to 2016 expect measles. As per WHO, the major vaccinations scheduled in the country were aP, Diphtheria, DTaP, HepA, HepB, and Rotavirus. The government of Italy has made 12 vaccines mandatory for the children in May 2017. The mandatory vaccines include polio, diphtheria, tetanus, hepatitis B, Haemophilus influenzae B, meningitis B, meningitis C, measles, mumps, rubella, whooping cough and chickenpox.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/italy-dna-vaccines-market

Italy is a significant contributor to the Gavi Alliance since 2006. The country is focusing on health system strengthening, newborn and child health, along with communicable and non-communicable diseases, and mental health. The market is segmented on the basis of type, application, and technology. Based on type, the market is segmented into animal DNA vaccine and human DNA vaccine. Based on application, the market is segmented into oncology, infectious disease and others. Based on technology, the market is segmented into plasmid DNA vaccine and plasmid DNA delivery.

Browse for Full Report Description@https://www.omrglobal.com/industry-reports/italy-dna-vaccines-market

The key market players that are active in the market include Eli Lilly and Co., GE Healthcare, GlaxoSmithKline PLC., Inovio Pharmaceuticals Inc., Merck & Co., Novartis AG, Pfizer Inc., Roche Diagnostics GMBH and Sanofi Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.

Market Segmentation

Italy DNA Vaccine Market by Type
Animal DNA Vaccine
Human DNA Vaccine
Italy DNA Vaccine Market by Technology
Plasmid DNA Vaccine
Plasmid DNA Delivery
Italy DNA Vaccine Market by Application
Oncology
Infectious Disease
Others
Company Profiles

Eli Lilly and Co.
GE Healthcare
Glaxosmithkline PLC.
Inovio Pharmaceuticals Inc.
Merck & Co.
Novartis AG
Pfizer Inc.
Roche Diagnostics GMBH
Sanofi Inc.






For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/italy-dna-vaccines-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari

Email: [email protected]
Contact no: +91 780-304-0404